Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : John, Mike & Tom's Wild World of Stocks -- Ignore unavailable to you. Want to Upgrade?

To: wlheatmoon who wrote (1249)	6/7/2000 9:35:00 AM
From: wlheatmoon	Read Replies (1) \| Respond to of 2850

Potential Value play...with Carl Icahn on board,,,,and a great book value....might be something worth buying for those with patience. FMO--$ 9 11/16, as of close on 6/6/00 Book Value of 27.78 PE 3.26 PS 0.12 PB 0.35 Last analyst...Bear Stearns downgrade from Buy to Neutral. last earnings news from thestreet.com Federal-Mogul (FMO:NYSE - news - boards), an auto parts maker, warned investors that its second-quarter and fiscal-2000 results would miss consensus estimates. The company said it would report second-quarter earnings of about 65 cents a share, below the nine-analyst estimate of a $1.12 profit, while fiscal-2000 earnings should come in at $3.00, which is also short of the 10-analyst estimate of $3.87. Federal-Mogul blamed the shortfall on softness in North American aftermarket results and negative currency fluctuations. Federal-Mogul staggered 2 3/8, or 20.1%, to 9 7/16. News from 3/29---- The Southfield, Mich.-based auto-parts supplier (FMO: news, msgs) advanced 3 3/16 to close at 15 7/16 following Tuesday's disclosure that a group controlled by investor Icahn acquired 5.2 percent of Federal's outstanding stock, according to documents filed with the SEC. Icahn, through High River LP and Riverdale LLC, purchased 3.6 million shares for more than $63.6 million for "investment purposes," according to documents filed late Tuesday.

To: wlheatmoon who wrote (1249)	6/7/2000 1:41:00 PM
From: John Pitera	Read Replies (2) \| Respond to of 2850

I'd bet that the genomics have that potential. As I have stated before, the biggies with potential drugs are MLNM, HGSI, and INCY. CRA has information and that's harder to value. I believe these are potential huge winners in the next decade. Mike, I really agree with you, as you can remember, I had very little interest in Biotech 12 or 14 months ago. But as research development snowball, I have obviously warmed up to the sector. You were at Ground Zero and pointed these stocks out even prior to the Dec-March run up. so MLMN, HGSI, and INCY are the big dogs -g- I'm sure we'll be talking much more about this...... John